Biomaterials Market - By Product (Metallic, Polymeric, Ceramic, Natural), By Application (Cardiovascular, Orthopedic, Dental, Plastic Surgery, Ophthalmology, Wound Healing, Neurology, Tissue Engineering) & Forecast, 2024 – 2032

Biomaterials Market - By Product (Metallic, Polymeric, Ceramic, Natural), By Application (Cardiovascular, Orthopedic, Dental, Plastic Surgery, Ophthalmology, Wound Healing, Neurology, Tissue Engineering) & Forecast, 2024 – 2032

Biomaterials Market Size

Biomaterials Market size is estimated to have reached USD 123.8 billion in 2023 and is projected to exhibit a CAGR of 12.6% from 2024 to 2032. There are several key drivers that contribute to the growth and development of the biomaterials industry such as, growing need for innovative biomaterials that can support and enhance these technologies, rising aging population, increasing prevalence of chronic diseases, such as cardiovascular diseases, diabetes, and orthopedic conditions, are becoming more common, and growing demand for aesthetic and cosmetic procedures.
 

Biomaterials play a critical role in regenerative medicine, which involves using biological materials to repair, replace, or regenerate damaged tissues and organs. The focus on regenerative medicine has driven the development of biomaterials that can promote tissue growth, angiogenesis, and cell differentiation.
 

Furthermore, as medical technology continues to advance, there is a growing need for innovative biomaterials that can support and enhance these technologies. Biomaterials play a crucial role in the development of medical devices, implants, and regenerative medicine products. In addition, the trend towards minimally invasive procedures requires biomaterials that can be delivered through small incisions or catheters. Biomaterials enable the development of minimally invasive devices and pharmaceutical drug delivery systems, which can improve patient outcomes and reduce recovery times. This emerging trend notably bolsters the demand for biomaterials.
 

COVID-19 Impact

The COVID-19 pandemic has had significant ramifications on the biomaterials market. The pandemic disrupted global supply chains, affecting the availability of raw materials and components necessary for biomaterial production. Lockdowns, travel restrictions, and factory closures led to manufacturing and distribution delays. Additionally, numerous research projects and clinical trials related to biomaterials were postponed or suspended due to restrictions on laboratory access and the prioritization of COVID-19 research. This impact reverberated into the introduction of new biomaterial products and technologies.
 

Conversely, the pandemic sparked a surge in demand for biomaterials used in medical devices, including face masks, respirators, and personal protective equipment (PPE). This surge also prompted increased research and development efforts towards new biomaterials intended for COVID-19 treatments, such as vaccines and drugs. However, while the demand for specific biomaterials utilized in COVID-19-related medical supplies surged, the requirement for biomaterials involved in elective procedures or non-urgent treatments dwindled due to the emphasis on essential care.
 

Overall, the COVID-19 pandemic wielded a substantial influence on the biomaterials industry. It drove an escalation in biomaterials demand, fueled research and development endeavors, and brought about material scarcity. As a result of these challenges, several companies encountered mounting difficulties in obtaining crucial components. Nevertheless, the pandemic also precipitated the implementation of new regulations aimed at ensuring the safety and efficacy of these products.
 

Biomaterials Market Trends

The biomaterials industry is undergoing transformation due to several influential trends that are shaping its trajectory of growth and advancement. Nanotechnology is being used to create biomaterials with unique properties, such as increased surface area, improved drug delivery capabilities, and enhanced mechanical strength. Nanomaterials can be engineered to interact with biological systems at the cellular and molecular levels. Moreover, biomaterials are often combined with other technologies, such as drug delivery systems or electronics, to create integrated medical devices. These combination products offer innovative solutions for various medical conditions.
 

Furthermore, with the rise of antibiotic-resistant infections, there's a growing interest in developing biomaterials with intrinsic antimicrobial properties. These materials can help prevent infections associated with medical devices. Additionally, there's a growing interest in biomaterials that are biodegradable or bioresorbable, meaning they can be broken down by the body over time. These materials are particularly valuable for temporary implants and drug delivery systems, as they eliminate the need for a second surgery to remove the implant. These trends are poised to propel the growth of the market throughout the forecast period.
 

Biomaterials Market Restraint

The high development cost of biomaterials arises from various challenges inherent in the complexity of biomaterial research, testing, and commercialization. These challenges contribute to the elevated expenses associated with bringing biomaterials to the market. The limitations are rooted in the difficulties and constraints that play a role in driving up the costs of introducing biomaterials to the market.
 

To ensure the safety and efficacy of biomaterials, regulatory authorities such as the FDA impose stringent regulations. These agencies' rigorous testing and documentation requirements can lead to extended development plans and increased expenditures. Furthermore, the process of developing biomaterials often entails an iterative approach involving trial and error to pinpoint the optimal combination of materials, properties, and processing techniques. This iterative process lengthens research and development timelines and adds to the associated expenses.
 

The challenges surrounding biomaterial development frequently result in prolonged timelines, heightened costs, and a sense of uncertainty. Nevertheless, the potential for innovative biomaterials to contribute to advancements in healthcare and enhanced patient outcomes can rationalize the investment for both companies and researchers engaged in this field.
 

Biomaterials Market Analysis

Based on product, the biomaterials market encompasses categories such as, metallic biomaterials, polymeric biomaterials, ceramic biomaterials, and natural biomaterials. During the year 2022, the metallic biomaterials segment dominated the market, constituting the largest share. Metals possess excellent mechanical properties, such as strength, stiffness, and ductility. These properties are crucial for applications where biomaterials need to withstand mechanical loads, such as orthopedic implants or dental implants. Moreover, metallic biomaterials are widely used in orthopedics for joint replacements, bone plates, screws, and spinal implants. The aging population and the need for solutions to address orthopedic issues drive the demand for these materials.
 

Based on product, the polymeric biomaterials segment is anticipated to witness over a CAGR of 13.1% during the forecast period. Polymers can be engineered with a wide range of properties, such as mechanical strength, flexibility, and biodegradability. This tunability allows them to be customized to specific applications, making them versatile for various medical needs. Additionally, polymeric biomaterials are widely used as carriers for controlled and targeted drug delivery. They can encapsulate and release therapeutic agents at a controlled rate, enhancing treatment efficacy and reducing side effects.
 

Based on application, the biomaterials market is segmented as cardiovascular, orthopedic, dental, plastic surgery, ophthalmology, wound healing, neurology, tissue engineering, and other applications. The cardiovascular held a dominant market share of around 23.3% in 2022 and is expected to grow at a significant pace during the analysis period. Cardiovascular diseases, such as coronary artery disease, heart failure, and arrhythmias, are major global health concerns. The high prevalence of these conditions drives the demand for biomaterial-based solutions to treat and manage them. According to American Heart Association, Inc. it was anticipated that 244.1 million individuals worldwide have ischemic heart disease (IHD) in 2020, with males being more affected than females.
 

Orthopedic segment was accounted for the second largest share of 17.8% in 2022. Orthopedic biomaterials play a critical role in joint replacement surgeries, including hip, knee, shoulder, and other joint replacements. These procedures offer improved mobility and quality of life to patients with degenerative joint diseases. This is expected to boost the segmental growth.
 

The plastic surgery segment is anticipated to witness over 13.5% CAGR between 2023 and 2032. The desire for improved appearance and self-confidence drives the demand for plastic surgery procedures. Biomaterials are used in cosmetic surgeries like breast augmentation, facial rejuvenation, and body contouring to achieve desired aesthetic outcomes. In addition, the development of biomaterials with advanced properties, such as biocompatibility, durability, and flexibility, contributes to their use in various plastic surgery applications.
 

North America biomaterials market accounted for the largest share of 37.3% in 2022 and is anticipated to grow at 12.7% during the forecast timeframe. North America boasts advanced healthcare infrastructure, including state-of-the-art medical facilities, research institutions, and a well-established regulatory framework. This facilitates the development, testing, and adoption of biomaterials. Moreover, like many developed regions, North America has an aging population that experiences an increased demand for medical interventions, including joint replacements, implants, and other biomaterial-based solutions.
 

Furthermore, North America places a high emphasis on healthcare and medical advancements. This focus drives demand for biomaterials to improve patient outcomes, enhance medical procedures, and develop innovative treatments, leading to the regional growth.
 

Biomaterials Market Share

Some of the major players operating in the biomaterials market are

• BASF SE
• Covestro AG
• ROYAL DSM
• Celanese Corporation
• Carpenter Technology Corporation
• Corbion
• EVONIK INDUSTRIES
• Berkeley Advanced Biomaterials
• CAM Bioceramics B.V.
• CeramTec GmbH
• Noble Biomaterials
• Victrex plc.
• Mitsubishi Chemical Group Corporation
• CoorsTek Inc.
• Zeus Company Inc.

These players focus on strategic partnerships, new product & service launch for market expansion.
 

Biomaterials Industry News

• In June 2023, IFF announced the launch of its pioneering Designed Enzymatic Biomaterials (DEB) technology for the large-scale creation of bio-based materials. DEB technology contributes to the rising need for ecologically sustainable, high-performance biopolymers.
   
• In June 2021, Evonik developed a novel 3D-printable PEEK biomaterial designed for medical applications. Known as VESTAKEEP Care M40 3DF, this polyether ether ketone filament has been developed by the specialized chemicals company for medical applications involving body contact of up to 30 days. This high-performance polymer is suitable for use in extrusion-based 3D printing techniques such as fused filament fabrication (FFF) or fused deposition modelling (FDM).
   

The biomaterials market research report includes an in-depth coverage of the industry with estimates & forecast in terms of revenue in USD Million from 2018 to 2032, for the following segments

Click here to Buy Section of this Report

By Product

• Metallic biomaterials
  • Titanium & titanium alloys
  • Stainless steel
  • Silver
  • Cobalt-chrome alloys
  • Gold
  • Magnesium
• Polymeric biomaterials
  • Polyester
  • Silicone rubber
  • Polyethylene
  • Polymethylmethacrylate
  • Polyetheretherketone
  • Nylon
  • Other polymeric biomaterials
• Ceramic biomaterials
  • Calcium phosphate
  • Zirconia
  • Calcium sulfate
  • Carbon
  • Aluminum oxide
  • Glass
• Natural biomaterials
  • Hyaluronic acid
  • Collagen
  • Silk
  • Alginates
  • Fibrin
  • Gelatin
  • Cellulose
  • Chitin

By Application

• Cardiovascular
  • Implantable cardiac defibrillators
  • Pacemakers
  • Stents
  • Vascular grafts
  • Sensors
  • Guidewires
  • Other cardiovascular applications
• Ophthalmology
  • Contact lens
  • Intraocular lens
  • Ocular tissue replacement
  • Synthetic corneas
  • Other ophthalmic applications
• Dental
  • Dental implants
  • Tissue regeneration materials
  • Bone grafts & substitutes
  • Dental membranes
  • Other dental applications
• Orthopedic
  • Joint replacement biomaterials
  • Orthobiologics
  • Bioresorbable tissue fixation products
  • Viscosupplementation
  • Spine biomaterials
  • Other orthopedic applications
• Wound healing
  • Fracture healing device
  • Adhesion barrier
  • Skin substitutes
  • Internal tissue sealant
  • Surgical hemostats
  • Other wound healing applications
• Plastic surgery
  • Soft tissue fillers
  • Facial wrinkle treatment
  • Craniofacial surgery
  • Bioengineered skins
  • Peripheral nerve repair
  • Acellular dermal matrices
  • Other plastic surgery applications
• Neurology
  • Neural stem cell encapsulation
  • Shunting systems
  • Hydrogel scaffold for CNS repair
  • Cortical neural prosthetics
  • Other neurology applications
• Tissue engineering
• Other applications

The above information is provided for the following regions and countries

• North America
  • U.S.
  • Canada
• Europe
  • Germany
  • UK
  • France
  • Spain
  • Italy
  • Rest of Europe
• Asia Pacific
  • Japan
  • China
  • India
  • Australia
  • Rest of Asia Pacific 
• Latin America
  • Brazil
  • Mexico
  • Rest of Latin America
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • Rest of Middle East & Africa